FEMRING Drug Patent Profile
✉ Email this page to a colleague
When do Femring patents expire, and when can generic versions of Femring launch?
Femring is a drug marketed by Millicent and is included in one NDA.
The generic ingredient in FEMRING is estradiol acetate. There are seventy-five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the estradiol acetate profile page.
Summary for FEMRING
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 13 |
Clinical Trials: | 1 |
Patent Applications: | 566 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for FEMRING |
Drug Sales Revenues: | Drug sales revenues for FEMRING |
What excipients (inactive ingredients) are in FEMRING? | FEMRING excipients list |
DailyMed Link: | FEMRING at DailyMed |
Recent Clinical Trials for FEMRING
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Columbia University | N/A |
Pharmacology for FEMRING
Drug Class | Estrogen |
Mechanism of Action | Estrogen Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for FEMRING
US Patents and Regulatory Information for FEMRING
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Millicent | FEMRING | estradiol acetate | INSERT, EXTENDED RELEASE;VAGINAL | 021367-001 | Mar 20, 2003 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Millicent | FEMRING | estradiol acetate | INSERT, EXTENDED RELEASE;VAGINAL | 021367-002 | Mar 20, 2003 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for FEMRING
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Millicent | FEMRING | estradiol acetate | INSERT, EXTENDED RELEASE;VAGINAL | 021367-001 | Mar 20, 2003 | ⤷ Try a Trial | ⤷ Try a Trial |
Millicent | FEMRING | estradiol acetate | INSERT, EXTENDED RELEASE;VAGINAL | 021367-002 | Mar 20, 2003 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for FEMRING
See the table below for patents covering FEMRING around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Turkey | 9501599 | ⤷ Try a Trial | |
Argentina | 002010 | UN DISPOSITIVO DE LIBERACION DE DROGA INTRAVAGINAL ADECUADO PARA LA ADMINISTRACION A UN MAMIFERO HEMBRA, UN PROCEDIMIENTO PARA PREPARARLO Y USO DEPRECURSORES DE 17ß-ESTRADIOL EN EL DISPOSITIVO Y PARA LA FABRICACION DEL DISPOSITIVO. | ⤷ Try a Trial |
European Patent Office | 0799025 | DISPOSITIFS DE LIBERATION INTRAVAGINALE DE MEDICAMENTS POUR L'ADMINISTRATION DE PRECURSEURS D'ESTRADIOL-17BETA (INTRAVAGINAL DRUG DELIVERY DEVICES FOR THE ADMINISTRATION OF 17BETA-OESTRADIOL PRECURSORS) | ⤷ Try a Trial |
Israel | 116433 | INTRAVAGINAL DRUG DELIVERY DEVICES FOR THE ADMINISTRATION OF 17β-OESTRADIOL PRECURSORS | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for FEMRING
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1214076 | 49/2008 | Austria | ⤷ Try a Trial | PRODUCT NAME: WIRKSTOFFKOMBINATION VON ETHINYLESTRADIOL UND DROSPIRENON; REGISTRATION NO/DATE: 1-27586 20080612 |
2782584 | 21C1058 | France | ⤷ Try a Trial | PRODUCT NAME: COMPOSITION CONTENANT A LA FOIS DE L'ESTRADIOL (17SS-ESTRADIOL), Y COMPRIS SOUS FORME HEMIHYDRATEE, ET DE LA PROGESTERONE; NAT. REGISTRATION NO/DATE: NL51886 20210421; FIRST REGISTRATION: BE - BE582231 20210406 |
0136011 | C00136011/03 | Switzerland | ⤷ Try a Trial | PRODUCT NMAE: ESTRADIOL UND MEDROXYPROGESTERONACETAT; REGISTRATION NO/DATE: IKS 55288 20000417 |
1453521 | 122015000093 | Germany | ⤷ Try a Trial | PRODUCT NAME: LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 87675.00.00 20150720; FIRST REGISTRATION: SLOWAKEI 17/0017/15-S 20150129 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |